Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

2.

[Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].

Li SQ, Fu XH, Liu J, Gu XS, Zhang J, Fan XN, Jiang YF, Miao Q.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Jan;34(1):23-7. Chinese.

PMID:
16626544
3.

B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.

Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, Wu W, Fan W, Su J, Hao G, Jiang Y, Xue L.

Acta Radiol. 2010 Jul;51(6):641-8. doi: 10.3109/02841851.2010.486804.

PMID:
20438292
4.

[Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].

Xie CL, Meng SR, Wang W, Chen SM, Li P, Feng XG.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):839-42. Chinese.

5.
6.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.

PMID:
20381654
7.

[Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].

Li S, Fu X, Dai Y, Liu C, Wang Y, Li W, Wu W, Gu X, Hao G, Fan W, Miao Q, Jiang Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Nov;43(11):954-9. Chinese.

PMID:
26888806
8.
9.

[Effect of primary percutaneous coronary intervention on plasma B-type natriuretic peptide in patients with acute myocardial infarction].

Liang JQ, Zhou XX, Huang YG, Zhang GX.

Di Yi Jun Yi Da Xue Xue Bao. 2005 Dec;25(12):1555-7. Chinese.

10.

NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction.

Rossetti E, Mariani M, Poli A, Palmerini T, Finazzi S, Lotzniker M, Sangiorgi D, De Servi S.

J Cardiovasc Med (Hagerstown). 2010 May;11(5):359-64. doi: 10.2459/JCM.0b013e3283366834.

PMID:
20051875
11.

[Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].

Wang CH, Xie XJ, Fang Q, Zhang SY, Fang ZJ, Jiang XF, Xie HZ, Liu ZY, Shen ZJ.

Zhonghua Yi Xue Za Zhi. 2011 Jan 25;91(4):265-8. Chinese.

PMID:
21418873
12.

[Effect of tirofiban in acute anterior myocardial infarction patients without ST segment resolution after primary percutaneous coronary intervention].

Peng JJ, Ma ZM, Ren LH, Ma ZM, Ren LH, Fu GQ, Jia KY, Lei LC, Ye HM.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Aug;37(8):725-8. Chinese.

PMID:
20021927
13.

[Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].

Xu XW, Zeng GY, Yang Y, Liu HX.

Yao Xue Xue Bao. 2002 Oct;37(10):758-62. Chinese.

PMID:
12567856
14.

Recombinant human brain natriuretic peptide therapy combined with bone mesenchymal stem cell transplantation for treating heart failure in rats.

Zhang J, Zhang L, Wu Q, Liu H, Huang L.

Mol Med Rep. 2013 Feb;7(2):628-32. doi: 10.3892/mmr.2012.1185. Epub 2012 Nov 15.

PMID:
23165804
15.

[Brain natriuretic peptide and left ventricular remodeling after emergency percutaneous coronary intervention in acute myocardial infarction patients].

Yu XY, Liu CZ, Wang JH, Sun JJ, Zhang HT, Luo HL, Huang CC, Jiang YQ.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Apr;20(4):204-6. Chinese.

16.

Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI.

Xing K, Fu X, Wang Y, Li W, Gu X, Hao G, Miao Q, Li S, Jiang Y, Fan W, Geng W.

Heart Vessels. 2016 Apr;31(4):490-8. doi: 10.1007/s00380-015-0642-8. Epub 2015 Jan 31.

PMID:
25637044
17.

Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

Damman P, Kuijt WJ, Woudstra P, Haeck JD, Koch KT, Gu YL, van Straalen JP, Fischer J, Tijssen JG, Krucoff MW, de Winter RJ.

Am Heart J. 2012 May;163(5):783-9. doi: 10.1016/j.ahj.2012.01.004.

PMID:
22607855
18.

[Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].

He B, Ding S, Pu J, Liu JP, Song W, Du YP, Shen JY, Jin SX, Sun Y, Shen L.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):349-52. Chinese.

PMID:
16776932
19.

[Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].

Fan WZ, Fu XH, Jiang YF, Gu XS, Wu WL, Li SQ, Liu J, Xue L, Wei YY, Hao GZ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Oct;35(10):908-13. Chinese.

PMID:
18206037
20.

In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.

Oduncu V, Erkol A, Tanalp AC, Dündar C, Tanboğa IH, Sırma D, Karagöz A, Karabay CY, Izgi A, Pala S, Tigen K, Kırma C.

Turk Kardiyol Dern Ars. 2011 Oct;39(7):540-8. doi: 10.5543/tkda.2011.01610.

Supplemental Content

Support Center